Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
. 2018 Apr 5;7(4):69.
doi: 10.3390/jcm7040069.

Assessment of the Pro12Ala Polymorphism in the PPAR-γ2 Gene Among Type 2 Diabetes Patients in a Nigerian Population

Affiliations
Free PMC article

Assessment of the Pro12Ala Polymorphism in the PPAR-γ2 Gene Among Type 2 Diabetes Patients in a Nigerian Population

Godwill Azeh Engwa et al. J Clin Med. .
Free PMC article

Abstract

The association between the Pro12Ala polymorphism of the PPARγ2 gene, type 2 diabetes (T2D), and obesity in certain ethnic populations has been reported. However, this relationship has not yet been described among diabetes patients in Nigeria. This study investigated the relationship between the Pro12Ala polymorphism in the PPARγ2 gene, obesity, and lipid abnormalities characterizing T2D among patients in Nigeria. This case-control study recruited 73 T2D and 75 non-diabetic (ND) patients. Demographic and clinical data were collected and blood glucose levels together with serum lipid profile for patients were measured. Pro12Ala polymorphism in the PPARγ2 gene was genotyped by restriction fragment length-Polymerase Chain Reaction (RFLP-PCR). The PPAR-γ2 gene (amplicon size = 270 base pair) was successfully amplified for all samples. Following restriction enzyme digestion and analysis by agarose gel electrophoresis, amplicons from samples showed a band of size 270 bp and were of the wild homozygous Pro/Pro genotype. Ala12 variant was totally absent from the study population. Obesity, estimated using Body Mass Index (BMI) and waist circumference (WC), was significantly higher (p < 0.05) in T2D patients compared to the non-diabetic patients. More so, the prevalence of lipid abnormalities; hypercholesterolaemia (TC > 200 mg/dL), hypertriglyceridaemia (TG > 150 mg/dL), high HDL (>100 mg/dL), and low HDL (<50 mg/dL) was significantly greater (p < 0.001) in T2D patients compared to non-diabetic patients. Results obtained further indicated lack of significant association between PPAR-γ2 gene polymorphism, T2D, and obesity. However, obesity and dyslipidaemia were strongly associated in T2D patients.

Keywords: Nigeria; PPAR-γ2 gene; Pro12Ala polymorphism; genetic association; lipid profile indices; obesity; type 2 diabetes.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
RFLP-PCR of PPARγ2 Pro12Ala Polymorphism. Samples were analyzed on a 3% agarose gel after restriction digest. D01–D03 = Samples for diabetic patients; ND01–ND03 = Samples for non-diabetic patients; UD = Undigested sample (control); MWM = Molecular weight marker.

Similar articles

See all similar articles

References

    1. World Health Organization . Global Report on Diabetes. WHO Press; Geneva, Switzerland: 2016.
    1. Mokdad A.H., Bowman B.A., Ford E.S., Vinicor F., Marks J.S., Koplan J.P. The continuing epidemics of obesity and diabetes in the United States. J. Am. Med. Assoc. 2001;286:1195–1200. doi: 10.1001/jama.286.10.1195. - DOI - PubMed
    1. World Health Organization Obesity and Overweight. [(accessed on 21 March 2018)];2018 WHO Fact Sheet. Available online: http://www.who.int/mediacentre/factsheets/fs311/en/
    1. Mooradian A.D. Dyslipidemia in type 2 diabetes mellitus. Nat. Clin. Prac. Endocrinol. Met. 2009;5:150–159. doi: 10.1038/ncpendmet1066. - DOI - PubMed
    1. Goldberg I.J. Diabetic dyslipidemia: Causes and consequences. J. Clin. Endocrinol. Met. 2001;8:965–971. doi: 10.1210/jcem.86.3.7304. - DOI - PubMed
Feedback